{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"slc6a3-related-dopamine-transporter-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"*SLC6A3-*related dopamine transporter deficiency syndrome (DTDS) is a complex movement disorder with a continuum that ranges from classic early-onset DTDS (by age 6 months) to atypical later-onset DTDS (in childhood, adolescence, or adulthood).","mondoId":"MONDO:0700117","node":{"canonicalSlug":"slc6a3-related-dopamine-transporter-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"SLC6A3-Related Dopamine Transporter Deficiency Syndrome","paragraphs":["*SLC6A3-*related dopamine transporter deficiency syndrome (DTDS) is a complex movement disorder with a continuum that ranges from classic early-onset DTDS (by age 6 months) to atypical later-onset DTDS (in childhood, adolescence, or adulthood).","*Classic early-onset DTDS:* Infants typically manifest nonspecific findings (irritability, feeding difficulties, axial hypotonia, and/or delayed motor development) followed by a hyperkinetic movement disorder (with features of chorea, dystonia, ballismus, orolingual dyskinesia). Over time, affected individuals develop parkinsonism-dystonia characterized by bradykinesia (progressing to akinesia), dystonic posturing, distal tremor, rigidity, and reduced facial expression. Limitation of voluntary movements leads to severe motor delay. Episodic status dystonicus, exacerbations of dystonia, and secondary orthopedic, gastrointestinal, and respiratory complications are common. Many affected individuals appear to show relative preservation of intellect with good cognitive development.","*Atypical later-onset DTDS:* Normal psychomotor development in infancy and early childhood. Attention-deficit/hyperactivity disorder (ADHD) is reported in childhood followed by later-onset manifestations of parkinsonism-dystonia with tremor, progressive bradykinesia, variable tone, and dystonic posturing. The long-term prognosis of this form of DTDS is currently unknown."],"reviewed":"2023-09-28","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:10:53.666747+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK442323/"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"movement disorder","mondoId":"MONDO:0005395","slug":null},{"kind":"parent","label":"hereditary neurological disease","mondoId":"MONDO:0100545","slug":null},{"kind":"child","label":"classic dopamine transporter deficiency syndrome","mondoId":"MONDO:0054835","slug":"classic-dopamine-transporter-deficiency"},{"kind":"child","label":"atypical dopamine transporter deficiency syndrome","mondoId":"MONDO:0700200","slug":"atypical-dopamine-transporter-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/dopamine-transporter-deficiency-syndrome"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK442323/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/26363\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700117\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-title</dd><dt>Upstream attribution</dt><dd>GeneReviews clinical characteristics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>*SLC6A3-*related dopamine transporter deficiency syndrome (DTDS) is a complex movement disorder with a continuum that ranges from classic early-onset DTDS (by age 6 months) to atypical later-onset DTDS (in childhood, adolescence, or adulthood).</p><p>*Classic early-onset DTDS:* Infants typically manifest nonspecific findings (irritability, feeding difficulties, axial hypotonia, and/or delayed motor development) followed by a hyperkinetic movement disorder (with features of chorea, dystonia, ballismus, orolingual dyskinesia). Over time, affected individuals develop parkinsonism-dystonia characterized by bradykinesia (progressing to akinesia), dystonic posturing, distal tremor, rigidity, and reduced facial expression. Limitation of voluntary movements leads to severe motor delay. Episodic status dystonicus, exacerbations of dystonia, and secondary orthopedic, gastrointestinal, and respiratory complications are common. Many affected individuals appear to show relative preservation of intellect with good cognitive development.</p><p>*Atypical later-onset DTDS:* Normal psychomotor development in infancy and early childhood. Attention-deficit/hyperactivity disorder (ADHD) is reported in childhood followed by later-onset manifestations of parkinsonism-dystonia with tremor, progressive bradykinesia, variable tone, and dystonic posturing. The long-term prognosis of this form of DTDS is currently unknown.</p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK442323/\" rel=\"noreferrer\">GeneReviews</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"slc6a3-related-dopamine-transporter-deficiency","sourceDocuments":[{"name":"GeneReviews: SLC6A3-Related Dopamine Transporter Deficiency Syndrome","reviewed":"2023-09-28","source_release":"2026-10-18 12:10:53.666747+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK442323/"},{"name":"GARD: SLC6A3-related dopamine transporter deficiency syndrome","reviewed":null,"source_release":"2026-10-25T03:43:30Z","url":"https://rarediseases.info.nih.gov/diseases/26363"},{"name":"MONDO: SLC6A3-related dopamine transporter deficiency syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0700117"}],"sourceNote":"","synonyms":["Dopamine transporter deficiency syndrome","DTDS"],"takeawayHtml":"","title":"SLC6A3-related dopamine transporter deficiency syndrome"},"schemaVersion":1}
